Battling Tax Fraud When State Revenues Are Decimated: Whistleblowers Are the Solution
States are currently facing significant fiscal challenges, with tax revenues weakening through late 2024 and into fiscal year 2025.
$137 Billion: The Amount Medicare Spends on Prescription Drugs Annually
Federal and state governments spend an enormous amount of their resources on prescription drugs.
Kickbacks and Stark Act Self-Referral Violations Continue to Be Key Focus Areas for Healthcare Fraud Enforcement
Healthcare fraud generates the bulk of the Government’s recoveries under the False Claims Act (“FCA”).
FY 2024 at the IRS Whistleblower Office: Improved Processing Times, the Third Highest Awards Total, and More
The IRS Whistleblower Office published their annual fiscal year (“FY”) report for 2024.
The Power of Private Equity Versus Enforcement: Whistleblowers Can Bridge the Gap
Over the past decade, private equity (PE) firms have dramatically increased their presence in the U.S. economy.
Whistleblowers Can Reverse the Decline in Defense FCA Cases
Each year in Fraud by the Numbers, we have lamented the historic decline in defense contracting False Claims Act (FCA) cases.
SEC Individual Charges
This installment of the Fraud by the Numbers series, we turn to the latest U.S. Securities and Exchange Commission (SEC) statistics on enforcement actions against individuals
State-Level Crypto Fraud Enforcement
Cryptocurrency-related fraud remains big business, with the FBI reporting $9.3 billion in cryptocurrency fraud losses in 2024, a 66% increase from 2023.
Kickbacks: A New Enforcement Priority in Medicare Advantage
This post is a combination of two oft-covered topics: kickbacks and the Medicare Advantage program.
Busting Modern-Day Trusts with the Help of Whistleblowers
Teddy Roosevelt is known as the youngest person to be sworn in as President of the United States when he assumed office after President McKinley was assassinated.
